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In addition to their roles in organizing the actin
cytoskeleton, members of the Rho family of GTP-
binding proteins have recently been implicated in a
plethora of other functions, including the activation of
kinase cascades and transcription factors, and the
control of endocytosis and secretion. Alongside this
expansion in proposed functions has been the
identification of multiple target proteins that interact
directly with Rho, Rac or Cdc42. Molecular connections
are now being made along the signalling pathways
activated by members of the Rho family.
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Introduction
It is eleven years since the first gene encoding a Rho
protein was cloned from Aplysia. Since then, eleven genes
encoding mammalian Rho family members have been
identified, and many homologous genes have also been
isolated from other species, from yeast to Drosophila and
Dictyostelium (Table 1) [1–7]. All of the proteins encoded
by these genes belong to the superfamily of Ras-related
GTP-binding proteins. In general, members of the super-
family cycle between a GTP-bound and a GDP-bound
form, and hydrolyse GTP [1]. The level of active, GTP-
bound protein is regulated by guanine-nucleotide
exchange factors (GEFs), GTPase-activating proteins
(GAPs), and guanine-nucleotide dissociation inhibitors
(GDIs) [8,9]. The alternation between GTP-bound and
GDP-bound forms is thought to allow members of the Ras
superfamily to act as bimodal switches, and they regulate
many intracellular signalling pathways. 
Early studies with Rho and Rac showed that they play
major roles in regulating remodelling of the actin
cytoskeleton induced by extracellular signals [1]. In addi-
tion, Rac was found to be an essential activator of the
NADPH oxidase in phagocytes [10]. In the past two years
or so, however, research on the Rho family has grown
exponentially, identifying many potential protein targets
and regulators, and revealing many apparently diverse
functions for the members of the family in regulating a
wide array of cellular responses — from endocytosis and
secretion to transcriptional regulation and growth control.
Several recent reviews have covered aspects of this field
[9,11–13]; this review is an attempt to assimilate some of
the latest exciting developments, focussing on the roles of
Rho family proteins in mammalian cells. 
The Rho family and the cytoskeleton 
It is now well established that three members of the Rho
family — Rho, Rac and Cdc42 — are involved in regulat-
ing the organization of the actin cytoskeleton. In fibrob-
lasts, it has been shown that Rho regulates the formation
of actin stress fibres, whereas Rac regulates lamellipodium
formation and membrane ruffling, and Cdc42 regulates
filopodium formation [1,11]. Rho is also required for the
formation and maintenance of focal adhesions, the sites at
which stress fibres are linked via integrins to the extra-
cellular matrix [14], whereas Rac and Cdc42 regulate the
formation of smaller ‘focal complex’ structures associated
with lamellipodia and filopodia [11]. Cell motility involves
the coordinated extension of lamellipodia and filopodia at
the leading edge of the cell, together with contraction of
the cell body and detachment of the rear edge, so Rho,
Rac and Cdc42 could play a crucial role in this process
[15]. Indeed, there is some evidence that Rho and/or Rac
are required for motile responses [16–18]. Rho family pro-
teins have also been implicated in the formation of the
actin-based contractile ring at cell division [7,9]. In addi-
tion, in the budding yeast Saccharomyces cerevisiae, Cdc42
and Rho1 are involved in regulating polarization of the
actin cytoskeleton during budding [9]. Until recently,
however, very little was known of the signal transduction
pathways acting downstream of these proteins, leading to
actin reorganization.
Rho and the actin cytoskeleton
A flurry of recent reports has established a model for a
direct molecular pathway connecting Rho and the actin
cytoskeleton. The key component of this pathway is
ROKa/Rho-kinase, one of the recently identified Rho-
interacting proteins (Table 2). ROKa/Rho-kinase and the
closely related protein ROKb/p160 are members of a
growing family of proteins that includes myotonic dystro-
phy kinase [19–22]. The sequences reported for Rho-
kinase [19] and ROKa [22] differ only at their amino
termini, where Rho-kinase is nine amino acids longer.
ROKa has been found to stimulate the formation of stress
fibres and focal adhesions when overexpressed in HeLa
cells [22]. The Rho-binding domain of ROKa is not
required for this response, nor is the response affected by
the presence of the Rho inhibitor C3 transferase (an
exoenzyme from Clostridium botulinum which inactivates
Rho by ADP-ribosylating it). Additionally, a ‘kinase-dead’
form of ROKa acts as a dominant-negative inhibitor of
Rho function, inducing disassembly of stress fibres and
focal adhesions. These results strongly suggest that ROKa
lies downstream of Rho in the pathway leading to stress
fibre formation; indeed, Rho can modestly stimulate the
kinase activity of ROKa/Rho-kinase in vitro [19,20]. 
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Table 1
Rho family members.
Mammalian S. cerevisiae S. pombe Drosophila Dictyostelium
Rho-like Rho (A, B, C) Rho1 Rho1
Rac-like Rac (1, 2) DRac (1,2) Rac (1,2,3,B)
Cdc42-like Cdc42, G25K Cdc42 Cdc42 DCdc42
Other RhoD Rho2 RacA
RhoE Rho3 RacC
RhoG Rho4 RacD
TC10 RacE
TTF
Table 2
Interacting ‘targets’ for Rho family proteins in mammalian cells.
‘Target’ Rho family interactions Proposed function in vivo 
Protein kinases PKN Rho ?
ROK/Rho-kinase/p160 Rho Actin reorganization 
PAK family Rac/Cdc42 SAPK/p38 kinase activation
p70S6K Rac/Cdc42 Mitogenic signalling
p120ACK Cdc42 ?
Phosphatases MLC phosphatase (MBS) Rho Actin reorganization
Adaptor proteins Rhophilin Rho ?
Citron Rho ?
p67phox Rac NADPH oxidase
WASP Cdc42 Actin reorganization
Lipid kinases PIP 5-kinase Rho/Rac Actin reorganization/ secretion
PI 3-kinase Rac/Cdc42 Actin reorganization/ mitogenic signalling
These proteins have been shown to interact specifically with GTP-
bound Rho, Rac and/or Cdc42 in the yeast two-hybrid system, by
affinity chromatography, and/or by overlay assay. The table does not
include the many GAPs for Rho family proteins, which may also have
effector functions [9].
Members of the Rho family, identified in the species shown, are listed
in groups according to their closest homology with the mammalian
proteins. Apart from Rho, Rac and Cdc42, clear homologues of the
mammalian proteins have not been identified in other species. Note
that Rho family proteins have also been identified in several species
that are not included here.
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A molecular link between ROKa/Rho-kinase and the actin
cytoskeleton is suggested by the observation that the
myosin-binding subunit (MBS) of myosin light-chain
(MLC) phosphatase is a good substrate in vitro for Rho-
kinase [19]. In fact, Rho itself binds to MBS and stimulates
the phosphorylation of MBS by Rho-kinase, thereby inhibit-
ing MLC phosphatase activity in vitro [23]. In fibroblasts
overexpressing RhoA, there is an increase in the phosphory-
lation both of MBS and of MLC itself. Phosphorylation of
MLC is known to induce a conformational change in
myosin II which increases its interaction with actin and
enables the formation of myosin filaments, observed as a
characteristic periodic pattern of myosin staining along
stress fibres [24–26]. Taken together, therefore, these data
suggest a model in which Rho induces stress fibre formation
by increasing the phosphorylation of MLC, thereby stimu-
lating the interaction of myosin with actin filaments (Fig. 1). 
Data accumulated by many laboratories over a number of
years serve to reinforce this model centred on the phos-
phorylation state of MLC. For example, eight years ago it
was found that injection into fibroblasts of antibodies
raised against MLC kinase induced a decrease in MLC
phosphorylation accompanied by the loss of stress fibres
[27]. Lysophosphatidic acid (LPA) rapidly stimulates
MLC phosphorylation, and various inhibitors of MLC
kinase have been reported to prevent LPA- and Rho-
induced contractility and stress-fibre formation [26,28].
Furthermore, it has been shown that Rho is involved in
regulating smooth-muscle cell contraction, a process
dependent on MLC phosphorylation [29]. The ability of
Rho to modulate MLC phosphorylation could explain its
involvement in cytokinesis, a process dependent on con-
traction mediated by myosin II and actin [9]. 
From the results described above, it is possible to con-
clude that Rho could induce the formation of contractile
stress fibres primarily by reorganizing existing actin fila-
ments, rather than by stimulating polymerization of actin.
In mast cells, however, Rho can stimulate new actin poly-
merization [30]; Rho is also required for actin polymeriza-
tion occurring during Shigella entry into HeLa cells [31].
In reality, there is likely to be a balance between reorgani-
zation and new polymerization, and the relative contribu-
tion of each may depend on the type of response involved. 
A link between Rho and actin polymerization may be pro-
vided by phosphatidylinositol 4-phosphate 5-kinase (PIP
5-kinase), which generates phosphatidylinositol 4,5-
bisphosphate (PIP2). Although so far no PIP 5-kinase iso-
forms have turned up in screens for Rho-interacting
proteins, Rho affinity columns can retain PIP 5-kinase,
and PIP 5-kinase immunoprecipitates contain Rho [32]. In
one report, however, PIP 5-kinase activity was not found
to bind significantly to Rho affinity columns [33], suggest-
ing that the interaction between PIP 5-kinase and Rho
may be indirect, and thus its detection may be dependent
on experimental conditions. Rho appears to act upstream
of PIP 5-kinase, as it stimulates PIP 5-kinase activity in cell
extracts [34]. As PIP2 can bind to, and affect the activities
of, several actin-binding proteins, it is possible that, by
increasing the level of PIP2, Rho could induce actin poly-
merization [11,13]. Interestingly, injection of anti-PIP2
Figure 1
A molecular model for Rho-induced stress fibre formation.
Lysophosphatidic acid (LPA) or another extracellular factor stimulates
an increase in Rho–GTP. This interacts with Rho-kinase and with the
myosin-binding subunit (MBS) of myosin light chain (MLC)
phosphatase. Rho–GTP activates Rho-kinase, which phosphorylates
MBS, leading to inactivation of the phosphatase. The phosphorylated
form of MLC therefore accumulates, and this leads to increased
binding of myosin to actin filaments and subsequently the formation of
stress fibres. Note that it is not known whether Rho can interact
simultaneously with Rho-kinase and MBS.
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antibodies into fibroblasts leads to the loss of stress fibres
[35], although the specificity of such antibodies in vivo is
difficult to ascertain. 
Rho and focal adhesions
In addition to stimulating the formation of stress fibres,
Rho induces focal adhesion formation and stimulates the
tyrosine phosphorylation of a number of focal adhesion
proteins, including pp125FAK, p130 and paxillin [1,36]. So
far, no tyrosine kinase has yet been identified as directly
interacting with Rho (Table 2). Instead, it is likely that
Rho-induced protein-tyrosine phosphorylation is indirect
and is mediated by one of the other Rho targets. One pos-
sible model for focal adhesion formation (Fig. 2) is that
Rho-mediated reorganization of actin filaments into con-
tractile stress fibres induces the clustering of integrins,
thereby catalysing the formation of focal adhesions and
the accompanying tyrosine phosphorylation of focal adhe-
sion proteins. Indeed, actin reorganization precedes
protein-tyrosine phosphorylation when activated Rho is
introduced into cells [36], and LPA-induced protein-tyro-
sine phosphorylation is prevented by inhibitors of MLC
kinase [26]. There is also evidence, however, that stress
fibre formation and focal adhesion formation may be sepa-
rate, but coordinated, events [11], and may therefore each
be regulated by a different downstream target of Rho.
Rac/Cdc42 and the actin cytoskeleton
The best-characterized target proteins for Rac and Cdc42
are the p21-activated kinase (PAK) family of serine/threo-
nine kinases ([37] and references therein). Work on these
kinases has concentrated on their involvement in regulating
cascades of other kinases that lead to transcription factor
activation (see below), but so far there has been no defini-
tive evidence to support or eliminate a role for them in reg-
ulating cytoskeletal responses induced by Rac or Cdc42.
As is the case for Rho, a potential link between Rac and
increased actin polymerization involves PIP2 generation.
Rac affinity columns can bind PIP 5-kinase [33], and Rac
can stimulate PIP2 production in permeabilized platelets
[38]. In this system, Rac and polyphosphoinositides
(including PIP2) induce uncapping of actin filaments,
which in intact cells would normally precede actin poly-
merization. Hartwig et al. [38] therefore postulate that
Rac-induced PIP2 generation would lead to actin polymer-
ization. The effect of Rho on PIP2 production in perme-
abilized platelets was not reported, but in this context it is
interesting to note that in experiments using fibroblast
cell extracts, Rho, but not Rac, was reported to stimulate
PIP 5-kinase activity [34]. The apparent discrepancy
between these results may reflect the involvement of dis-
tinct isoforms of PIP 5-kinase responsive to Rac or Rho. It
would therefore be of great interest to investigate the
actions of Rho and other Rho family proteins, especially
Cdc42, in platelets.
A specific connection between Cdc42 and the actin
cytoskeleton has recently been suggested by studies on
the Wiskott-Aldrich syndrome (WAS) protein (WASP)
[39]. The WAS gene was initially isolated by positional
cloning and shown to be mutated in WAS patients. It has
subsequently been isolated as encoding a protein that
interacts with Cdc42 and weakly with Rac. WASP expres-
sion is restricted to haematopoietic cells [40]. Although
WASP has not been shown to localize to filopodia or affect
filopodium formation, it does induce an unusual form of
actin reorganization. When overexpressed in several cell
types, including Jurkat cells (which normally express
WASP), it is found to co-localize with clusters of polymer-
ized actin [40] This effect is inhibited by co-expression of
dominant-negative Cdc42, but not Rac or Rho. These
results indicate that there is an interaction between WASP
and the actin cytoskeleton involving Cdc42, but a direct
role of WASP in Cdc42-induced filopodium formation has
yet to be established. Interestingly, WASP also binds to
c-Src family tyrosine kinases [41], which are known to reg-
ulate actin cytoskeletal organization [42] and may there-
fore be involved in Cdc42 signalling.
So far there has been little evidence that GAPs for Rho
family proteins might function as effector proteins, in
addition to acting as down-regulators. It appears, however,
that n-chimaerin, a Rac/Cdc42 GAP, may play a role in
Rac/Cdc42-mediated actin reorganization [43]. Micro-
injection of the n-chimaerin GAP domain alone inhibits
Rac-mediated lamellipodium formation in fibroblasts, in
line with previous observations on GAP domains [1]. In
contrast, microinjection of the full-length protein induces
the formation of both filopodia and lamellipodia, and
these responses are dependent on Cdc42 and Rac pro-
teins, respectively. The Cdc42- or Rac-binding domain of
n-chimaerin is essential for these responses, suggesting
that it interacts productively with Rac and Cdc42 to
mediate downstream signalling. Interestingly, n-chimaerin
also has a phorbol-ester-binding domain, and one possibil-
ity is that n-chimaerin acts by assisting the correct localiza-
tion of Rac and Cdc42 to the plasma membrane through
its ability to bind phospholipids. 
Rho family proteins and growth control
There is accumulating evidence that Rho family proteins
not only regulate cell morphology and actin organization,
but also interact with a number of proteins regulating cell
growth and mitogenesis. The initial suggestion that the
Rho family might play a role in growth control came from
the isolation of a number of oncogenes which encode
exchange factors for Rho family members [9]. More
recently, Rac and Rho have been shown to have
transforming ability in some cell types, and to be required
for Ras-induced transformation of fibroblasts [12]. Rac is
also required for v-Abl to activate a mitogenic program
[44]. In addition, it has been reported that microinjection
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of Rho, Rac or Cdc42 proteins into Swiss 3T3 fibroblasts
stimulates DNA synthesis, and that inhibitors of these
proteins block growth-factor-induced DNA synthesis [45].
The pathways used by these proteins to induce DNA syn-
thesis are not clear, but there are several possibilities.
Rho and growth control
One mechanism whereby Rho could induce a mitogenic
response in cells is through its ability to activate the tran-
scription factor SRF, which binds to the serum response
element (SRE) found in the promotors of a number of
‘early’ genes induced by growth factors [46]. Expression of
Rho, Rac or Cdc42 stimulates the activity of SRF, but only
Rho is required for serum- and LPA-induced SRF activa-
tion. The signalling pathway linking Rho to SRF has not
been delineated, and it is possible that any of the proteins
which interact with GTP-bound Rho could be involved
(Table 2). Interestingly, the S. cerevisiae homologue of
Rho, Rho1p, has been shown to interact directly with
Pkc1p, a yeast protein kinase C homologue, leading to
activation of a mitogen-activated protein (MAP) kinase
cascade [47]. Rho does not activate any of the known
MAP kinase cascades in mammalian cells [46,48,49], but it
may activate a related pathway, perhaps involving the
Rho-interacting kinase PKN.
Rac/Cdc42 and growth control
The last year has seen an explosion of studies of the roles
of Rac and Cdc42 in the activation of kinase cascades that
could potentially be involved in mitogenic responses. It
has been known for a while that Rac and Cdc42 interact
with and activate the PAK family of serine/threonine
kinases. A yeast homologue of PAK, Ste20, acts down-
stream of Cdc42 in the MAP kinase pathway activated by
pheromones [50]. Several reports have now established
links in mammalian cells between Rac/Cdc42, PAKs and
the so-called ‘stress-activated’ protein kinase cascades,
leading to activation of the stress-activated protein kinases
(SAPKs, also known as Jun N-terminal kinases, or JNKs)
and p38 kinases [51]. Using transient transfection assays, it
has been shown that expression of activated forms of Rac
and Cdc42 leads to increased SAPK and p38 kinase activ-
ity, and that dominant-negative Rac/Cdc42 mutants
inhibit the activation of these kinases by some extracellu-
lar factors [45,48,49,52]. Furthermore, overexpression of
PAK1 leads to activation of the p38 kinase [53], and
expression of a constitutively active PAK stimulates SAPK
activity ([37,52]. In all of these experiments, little or no
activation of p42/p44 MAP kinases was observed, in con-
trast to the strong stimulation of MAP kinases by Ras.
Whether Rac/Cdc42-mediated activation of SAPK and p38
kinase can contribute to mitogenic stimulation of cells is
unclear. These kinases are normally activated most
potently by ‘stress’ stimuli which do not normally stimu-
late DNA synthesis [51]. But SAPK and p38 kinase are
also weakly activated by some growth factors, and several
transcription factors have recently been identified as
targets for these kinases [54]. It is therefore possible that
they can, in combination with other signals, contribute to
mitogenesis by inducing expression of genes required for
cell-cycle progression (Fig. 3). 
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A hypothetical model for Rho-induced focal adhesion formation. In
unstimulated cells (a), integrins are not extensively clustered, but are
associated with various proteins, including for example pp125FAK (FAK),
talin (T), and a-actinin (a-act). They are thereby associated with short
actin filaments, but myosin is not associated with these filaments.
Following activation of Rho (b), for example by LPA, myosin light chain
(MLC) becomes phosphorylated and myosin interacts productively with
actin filaments, leading to the formation of contractile stress fibres.
These fibres pull integrins and their associated proteins into clusters
within the plasma membrane. Clustering of integrins leads to the
phosphorylation of associated proteins (c), for example pp125FAK,
which can autophosphorylate itself on tyrosine residues. This allows the
association of many other signalling and structural proteins with the
complex, forming focal adhesions and leading to downstream signalling.
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Although this model is attractive, it is important to note that
all of the data on the activation of these kinase pathways by
Rac and Cdc42 come from long-term transient transfection
assays. What is still lacking is direct evidence that Rac or
Cdc42 can rapidly activate the kinases upon introduction
into cells, in the same way as Ras has been shown to
activate p42/p44 MAP kinases [55]. In addition, although
platelet-derived growth factor (PDGF) has been reported
to stimulate GTP loading on Rac, it is not yet known
whether Rac or Cdc42 is similarly activated by stress
stimuli such as tumour necrosis factor-a (TNF-a). In fact,
agents that rapidly induce Rac-dependent ruffling/lamel-
lipodia, such as PDGF, are only at best very weak activators
of SAPK and p38 kinase, whereas TNF-a, which potently
stimulates these kinases, does not detectably induce mem-
brane ruffling in fibroblasts [51,56]. It is therefore possible
that the effects observed in transient transfection assays
reflect an indirect role of Rac and Cdc42 in producing or
modulating signals leading to a stress response. Alterna-
tively, stress signals may normally act directly through a dif-
ferent member of the Rho family, but Rac and Cdc42 are
able to induce the same effects when overexpressed.
A second link to mitogenic signalling pathways was
revealed recently when it was reported that Rac and Cdc42
interact with and activate pp70S6K both in vitro and in vivo
[57]. This kinase plays an important role in the progression
of cells from G1 to S phase of the cell cycle, and is gener-
ally activated by mitogenic stimuli within minutes [58]. In
transient transfections, activated Rac and Cdc42 induce an
increase in the activity of co-transfected pp70S6K, whereas
dominant-negative forms of Rac and Cdc42 inhibit growth
factor-induced activation of pp70S6K. Neither SAPK nor
p38 kinase appears to mediate the effects of Rac and
Cdc42. Instead, GTP-bound Rac and Cdc42 can directly
and specifically interact with pp70S6K in vitro, and they co-
immunoprecipitate from cells. How Rac and Cdc42 acti-
vate pp70S6K in cells is unclear, as they do not stimulate its
kinase activity in vitro. It would be of interest to determine
whether phosphoinositide (PI) 3-kinase is also present in a
complex with Rac/Cdc42 and pp70S6K, as Rac and Cdc42
can both interact with PI 3-kinase [33,59], and PI 3-kinase
is a key upstream regulator of pp70S6K [58]. Perhaps Rac
and Cdc42 act to facilitate interactions between pp70S6K
and its direct activators. 
Finally, it has been reported that Rac is required for
arachidonic acid release induced by epidermal growth
factor (EGF), and that it also mediates calcium influx in
response to EGF but not to all growth factors [60,61]. The
signalling pathways linking Rac to these responses remain
to be elucidated, but it is likely that they are important
during mitogenic stimulation (Fig. 3).
Other responses regulated by the Rho family 
The requirement for Rac in regulating the NADPH
oxidase of phagocytes has been known for several years —
as long as Rac’s involvement in actin reorganization [10].
More recently, however, several other functions have
been attributed to the Rho family, and these effects are
apparently independent of their effects on actin reorgani-
zation. For example, Rac and Rho have been shown to
regulate secretion in permeabilized mast cells. Recombi-
nant Rac and Rho proteins enhance secretion, whereas C3
transferase and dominant-negative Rac inhibit secretion
induced by the non-hydrolysable GTP analogue GTPgS
[62]. Independently, Rac was purified from mast cells as a
factor which could enhance secretion [63]. Comparison of
the actin reorganization responses to Rac and Rho with
the secretory responses shows that although actin reorga-
nization is closely linked to secretion, the two responses
are independently regulated [64].
Rho and Rac have also been implicated in the regulation of
endocytosis [65,66]. In Xenopus oocytes, Rho has been
found to enhance constitutive endocytosis/pinocytosis,
whereas C3 transferase inhibits the process [66]. Con-
versely, in mammalian cells and in a cell-free endocytosis
system, Rho and Rac inhibit receptor-mediated endocytosis
Figure 3
Downstream signalling pathways activated by Rac and Cdc42 which
may lead to mitogenesis.
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of clathrin-coated vesicles [65]. As is the case for secretion,
these effects are apparently not mediated by changes in
actin organization. Interestingly, one of the three closely
related Rho proteins, RhoB, is localized to early endosomes,
suggesting a role in endocytosis [67]. 
Is there a common mechanism underlying the effects of
Rho and Rac on secretion and endocytosis? It is possible
that their involvement in these processes reflects their
ability to alter membrane phospholipid composition, for
example through activation of PIP 5-kinase, PI 3-kinase or
phospholipase D [68]. Indeed, it is becoming increasingly
clear that phosphoinositides play an important role in reg-
ulating vesicle traffic [69], and there is evidence that PIP
5-kinase and phospholipase D are involved in secretion
[68,69]. A comprehensive assessment of the effects of
other Rho-related proteins, in particular Cdc42, on secre-
tion and endocytosis would provide considerably more
information on the specificity of these responses. 
The inhibitory effects of Rho and Rac on receptor-
mediated endocytosis suggest one interpretation of the
mitogenic effects of Rho family proteins (Fig. 4). If
receptor-mediated endocytosis is inhibited in cells over-
expressing Rho or Rac (Cdc42 remains to be tested), then
perhaps growth factor receptors that would normally be
down-regulated by endocytosis instead stay for longer
periods on the cell surface. Cells would then be sensitized
to, or show prolonged responses to, growth factors for which
the receptors are normally down-regulated by endocytosis,
and thereby show an increased response to those factors;
the growth factors might be present in serum or as
autocrine factors. It has been argued that, because little or
no p42/p44 MAP kinase activation is observed in
Rac/Cdc42-transfected cells, Rac and Cdc42 do not act
non-specifically to up-regulate signalling. But there may be
tighter regulation of p42/p44 MAP kinase activity than of
some signalling pathways, and even a transient activation of
p42/p44 MAP kinases may be sufficient to induce a mito-
genic response [70]. It should be possible to test the model
shown in Figure 4, for example by investigating the levels
of various receptors on the cell surface and their ability to
be internalized. 
New Rho family members — new modes of
action?
Recently, two new members of the Rho family of proteins,
RhoE and TTF, have been characterized [2,3]. Although
their biological functions have not been elucidated, both
proteins have some unusual features which suggest that
they may act in fundamentally different ways to other
members of the Ras superfamily. In RhoE, three amino
Figure 4
A model for the regulation of mitogenic
signalling by Rho family proteins. Upon growth
factor binding, receptors activate multiple
pathways, ultimately leading to DNA
synthesis. Rho family proteins may be directly
involved in activating some of these pathways.
Following ligand binding, many receptors
cluster into clathrin-coated pits and are
endocytosed, eventually leading to down-
regulation of receptor signalling. By blocking
endocytosis, activated Rho and Rac (and
possibly Cdc42) would prolong receptor
signalling, leading to constitutive activation of
downstream pathways. Some of these
pathways may be down-regulated by
feedback mechanisms. 
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acids — residues equivalent to 12, 59 and 61 of Ras —
which are almost universally conserved in the Ras and
Rho subfamilies are substituted with amino acids which
make Ras oncogenic; in TTF, amino acids equivalent to
residues 12 and 61 in Ras are similarly substituted. When
tagged RhoE protein is expressed and immunoprecipi-
tated from cells, it is found exclusively bound to GTP, and
in vitro it does not detectably hydrolyse GTP, consistent
with the hypothesis that the amino-acid substitutions
(with respect to Ras) inhibit GTPase activity [2]. Indeed,
when these three amino acids are mutated to the residues
found in other Rho family members, the protein is now
able to hydrolyse GTP. If RhoE really binds only to GTP,
does it no longer act as a regulatable switch, turned on by
the exchange of GDP for GTP? Maybe GTP is simply
acting as an essential co-factor to maintain protein struc-
ture, and RhoE activity is regulated in some other way, for
example by phosphorylation (as has been suggested for
RhoA) [71], by altered cellular localization, or by
reversible binding to an inhibitory protein such as Rho-
GDI [1]. Clearly, we still have a lot to discover about this
fascinating family of proteins.
Conclusions and perspectives
It is becoming increasingly clear that proteins of the Rho
family carry out diverse functions and have the potential to
interact with a large number of other proteins. The ability
of GTP-binding proteins to communicate with many down-
stream targets is best illustrated by Ras itself, although the
functional consequences of most of its interactions are still
unclear. Studies using a panel of Ras mutants are beginning
to provide information on the specific signalling roles of
some Ras target proteins [72,73]; no doubt similar studies
with the Rho family will help to determine which targets
mediate the various responses they generate. In addition,
expression of each target protein (Table 2) in cells, along
with the isolation of interacting proteins, will provide
important information on their downstream connections. 
One of the major challenges in the Rho field is that of
specificity. Not only are there 11 members of the Rho
family, but there are ever-growing families of regulators and
target proteins. One concern with many experimental
approaches used to study protein function is that overex-
pression of a protein may artificially induce a response nor-
mally mediated in vivo by a related family member. In
many cases, more detailed studies using a wide range of
Rho family proteins and mutants will help to resolve this
issue. In addition, investigating the intracellular localization
of regulators, GTP-binding proteins and targets will eluci-
date which proteins are accessible to each other in cells.
In conclusion, it appears that members of the Ras super-
family have evolved to present a surface in their GTP-
bound conformation capable of interacting in different
ways with several proteins, and therefore coordinating the
activation of multiple pathways. At the moment, we have
many functions for Rho family proteins, and many targets,
with only a few connections between the two. But research
is moving so rapidly and productively in this field that no
doubt many new links will be forged in the near future. 
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